Page 39 - Avoid Food and Drug Interactions
P. 39

Myth: Timing of ILE

                                                                                            ASPEN-SCCM guidelines suggest withholding or limiting ILE for 7-10 days in
                                                                                            critically ill patients1

                                                                                            Battistella2: Increased infxn with ILE               Gerlach3: No difference in infxn (early vs delayed)

© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved.  1. McCLave SA. JPEN. 2016;40(2):159-211.
                                                                                            2. Battistella FD. J Trauma. 1997;43(1):52-60.
                                                                                            3. .Gerlach AT. Surg Infect. 2011;12(1):43-47.

                                                                                                                                                 73

© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved.  Current Practice: Timing of Lipids

                                                                                            • Recommendations to delay ILE use based only on SO-ILE

                                                                                                o Evidence based on well-nourished patients

                                                                                            • ESPEN guidelines encourage use of ILE with PN initiation
                                                                                            • Daily lipids recommended to meet energy requirements and reduce

                                                                                              dextrose load
                                                                                            • Newly available lipids provide alternative options

                                                                                            Singer P.Clinical Nutrition(2019);38 :(2019) 48-79.
                                                                                            McClave S. JPEN (2016); 40(2):159–211.

                                                                                                                                                 74

                                                                                                                                                 39
   34   35   36   37   38   39   40   41   42   43   44